Users Stopping Weight-Loss Jabs Gain Back Pounds Four Times Faster Than Those on Conventional Diets

Fresh analysis indicates that people who stop using blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds far faster than those who halt traditional lifestyle plans.

Published data in a leading health publication shows that while obese individuals can lose a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"People buying these treatments must be aware of the potential of fast rebound weight gain when the therapy concludes," warns researcher Dr. Susan Jebb.

This pace of regain implies a return to original mass within about 18 months.

Weighing Approaches

The research, which examined dozens of trials involving over 9,000 of participants, compared the effects of these new drugs with conventional dieting.

Researchers note that people who shed pounds through diet and exercise generally have a slower weight regain—approximately 0.1 kg a month—after stopping.

Explaining the Quick Regain

Nutrition scientists believe the mode of action of the injections is key to understanding the heightened regain.

The injections copy a natural hormone called glucagon-like peptide-1, which helps regulate appetite.

"Artificially providing the hormone levels several times higher than the body's typical production could lead to the body to produce less of its own natural hormone, and may also reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.

"Stopping of this medication results in appetite is no longer kept in check, making excessive eating much more probable."

A Chronic Issue?

Health authorities suggest the injections for people with obesity-related health risks, alongside prescribed lifestyle changes.

Many experts say that, given the likelihood of relapse, the therapy is often life-long.

This opinion is echoed by pharmaceutical companies, who say that the findings "emphasize the chronic nature of obesity," comparing it to managing conditions like diabetes.

User Testimonies

Individuals who have come off the medication describe a sudden resurgence of hunger.

"It was like something activating and I was suddenly starving," described a patient.

This challenge is worsened if users have not established permanent lifestyle or habit modifications during therapy.

Growing Use

Figures indicate that a significant number of adults in the UK have used these injections in the last 12 months, with interest continuing to grow.

• Use is higher among women compared to males.
• The 40s and 50s age group shows the greatest level of interest.
• Many access the drugs through private healthcare rather than public health services.

Finally, researchers emphasize that while these medications are powerful agents for weight loss, they are not a magic solution and lasting health benefits relies on integrated behavioural management.